Segall Bryant & Hamill’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-48,580
| Closed | -$14.9M | – | 303 |
|
|
2023
Q3 | $14.9M | Sell |
48,580
-562
| -1% | -$177K | 0.17% | 153 |
|
|
2023
Q2 | $15.2M | Sell |
49,142
-1,233
| -2% | -$358K | 0.16% | 170 |
|
|
2023
Q1 | $14.4M | Sell |
50,375
-1,021
| -2% | -$278K | 0.16% | 181 |
|
|
2022
Q4 | $13.7M | Buy |
51,396
+591
| +1% | +$163K | 0.15% | 181 |
|
|
2022
Q3 | $13.1M | Sell |
50,805
-282
| -0.6% | -$81.5K | 0.16% | 170 |
|
|
2022
Q2 | $14.2M | Sell |
51,087
-231
| -0.5% | -$69.4K | 0.16% | 160 |
|
|
2022
Q1 | $17.3M | Sell |
51,318
-10,799
| -17% | -$3.64M | 0.17% | 151 |
|
|
2021
Q4 | $25.7M | Sell |
62,117
-3,601
| -5% | -$1.31M | 0.24% | 116 |
|
|
2021
Q3 | $21M | Sell |
65,718
-5,245
| -7% | -$1.71M | 0.2% | 126 |
|
|
2021
Q2 | $20.9M | Sell |
70,963
-40,653
| -36% | -$11.6M | 0.2% | 130 |
|
|
2021
Q1 | $30.8M | Buy |
111,616
+25,935
| +30% | +$6.7M | 0.3% | 93 |
|
|
2020
Q4 | $22.4M | Sell |
85,681
-7,076
| -8% | -$1.7M | 0.25% | 106 |
|
|
2020
Q3 | $21M | Sell |
92,757
-4,088
| -4% | -$936K | 0.28% | 86 |
|
|
2020
Q2 | $20.8M | Sell |
96,845
-1,920
| -2% | -$363K | 0.35% | 75 |
|
|
2020
Q1 | $16.1M | Sell |
98,765
-2,524
| -2% | -$486K | 0.33% | 72 |
|
|
2019
Q4 | $21.3M | Sell |
101,289
-4,255
| -4% | -$829K | 0.33% | 76 |
|
|
2019
Q3 | $20.3M | Sell |
105,544
-3,087
| -3% | -$597K | 0.32% | 77 |
|
|
2019
Q2 | $20.1M | Sell |
108,631
-4,123
| -4% | -$741K | 0.3% | 86 |
|
|
2019
Q1 | $19.9M | Sell |
112,754
-2,537
| -2% | -$399K | 0.31% | 86 |
|
|
2018
Q4 | $16.3M | Sell |
115,291
-4,417
| -4% | -$699K | 0.28% | 101 |
|
|
2018
Q3 | $20.4M | Sell |
119,708
-6,546
| -5% | -$1.09M | 0.3% | 84 |
|
|
2018
Q2 | $20.7M | Buy |
126,254
+89,876
| +247% | +$14M | 0.31% | 82 |
|
|
2018
Q1 | $5.58M | Sell |
36,378
-760
| -2% | -$120K | 0.13% | 177 |
|
|
2017
Q4 | $5.68M | Buy |
37,138
+621
| +2% | +$90K | 0.13% | 181 |
|
|
2017
Q3 | $4.93M | Buy |
36,517
+540
| +2% | +$70.4K | 0.11% | 193 |
|
|
2017
Q2 | $4.45M | Buy |
35,977
+447
| +1% | +$54.5K | 0.1% | 209 |
|
|
2017
Q1 | $4.26M | Sell |
35,530
-1,290
| -4% | -$154K | 0.1% | 205 |
|
|
2016
Q4 | $4.31M | Buy |
36,820
+1,960
| +6% | +$233K | 0.11% | 193 |
|
|
2016
Q3 | $4.26M | Sell |
34,860
-263
| -0.7% | -$29.9K | 0.11% | 196 |
|
|
2016
Q2 | $3.98M | Sell |
35,123
-5,612
| -14% | -$651K | 0.1% | 198 |
|
|
2016
Q1 | $4.7M | Sell |
40,735
-400
| -1% | -$41.1K | 0.12% | 197 |
|
|
2015
Q4 | $4.3M | Sell |
41,135
-400
| -1% | -$42.2K | 0.1% | 225 |
|
|
2015
Q3 | $4.08M | Buy |
41,535
+38,077
| +1,101% | +$3.78M | 0.1% | 233 |
|
|
2015
Q2 | $335K | Buy |
3,458
+150
| +5% | +$14.3K | 0.01% | 472 |
|
|
2015
Q1 | $310K | Hold |
3,308
| – | – | 0.01% | 480 |
|
|
2014
Q4 | $295K | Hold |
3,308
| – | – | 0.01% | 486 |
|
|
2014
Q3 | $269K | Hold |
3,308
| – | – | 0.01% | 501 |
|
|
2014
Q2 | $267K | Sell |
3,308
-940
| -22% | -$75.5K | 0.01% | 508 |
|
|
2014
Q1 | $339K | Sell |
4,248
-27
| -0.6% | -$2.22K | 0.01% | 494 |
|
|
2013
Q4 | $351K | Buy |
+4,275
| New | +$323K | 0.01% | 492 |
|
Other funds holding ACN
Segall Bryant & Hamill's ACN Position: Q4 2023 in Review
Segall Bryant & Hamill sold out of Accenture (ACN) in Q4 2023, closing a stake of 48,580 shares — an estimated $14.9M sold.
Segall Bryant & Hamill first reported a position in ACN in Q4 2013 and held it in 40 quarters. The position peaked at $30.8M in Q1 2021. 2,311 funds tracked by Wall St. Rank hold ACN as of Q4 2023.
- Segall Bryant & Hamill reported no remaining Accenture position as of Q4 2023 after selling out during the quarter.
- Segall Bryant & Hamill sold 48,580 Accenture shares in Q4 2023, an estimated $14.9M.
- Segall Bryant & Hamill first reported a position in Accenture in Q4 2013 and held it in 40 quarters.
- Segall Bryant & Hamill's Accenture position peaked at $30.8M in Q1 2021.
- 2,311 funds tracked by Wall St. Rank held Accenture as of Q4 2023.
Based on Segall Bryant & Hamill's 13F filing for Q4 2023, filed 14 Feb 2024.